Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
M. Nakamura
Relative impact of T4 and N2 on the efficacy of 3 versus 6 months of adjuvant CAPOX for high-risk stage II and stage III colon cancer: ACHIEVE and ACHIEVE-2 trials
Background Results in the IDEA Collaboration have allowed clinical practice guidelines to prioritise 3-months (3m) of CAPOX for the ad...
Takeharu Yamanaka ;
Y. Maehara ;
M. Kotaka ;
M. Mori ;
D. Manaka ;
M. Shiozawa ;
Y. Sakamoto ;
Y. Munemoto ;
T. Eto ;
Kohei Shitara , MD;
A. Shiomi ;
J. Hasegawa ;
A. Makiyama ;
A. Takagane ;
Takayuki Yoshino , MD, PhD;
Eiji Oki ;
T. Kato ;
T. Mizushima ;
M. Nakamura ;
E. Sunami ;
K. Yamazaki ;
A. Ohtsu ;
06/30/2020
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody
Background Although the selection of anti-EGFR antibody as first-line treatment for metastatic colorectal cancer (mCRC) patients is now decided based on primary tumor lo...
H. Okuda ;
Y. Sasaki ;
Yasuhiro Sakata ;
M. Nakamura ;
S. Yuki ;
Taisei J. Kobayashi , MD;
Y. Komatsu ;
M. Dazai ;
T. Sasaki ;
H. Nakatsumi ;
A. Sato ;
A. Ueda ;
Ayako Yoshikawa , MD;
K. Ito ;
Y. Kawamoto ;
R. Saito ;
T. Yamamura ;
M. Yagisawa ;
A. Ishiguro ;
O. Muto ;
K. Hatanaka ;
06/28/2021
Featured CME Course
Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes
Upcoming Events
February 2 – February 5
February 7 – February 9
February 27 – March 1
March 17 – March 19
March 22 – March 23
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
May 1 – May 3
See Full Calendar